Progressive familial intrahepatic cholestasis: diagnosis, management, and treatment
- PMID: 30237746
- PMCID: PMC6136920
- DOI: 10.2147/HMER.S137209
Progressive familial intrahepatic cholestasis: diagnosis, management, and treatment
Abstract
Progressive familial intrahepatic cholestasis (PFIC) is a group of autosomal recessive cholestatic liver diseases which are subgrouped according to the genetic defect, clinical presentation, laboratory findings and liver histology. Progressive liver fibrosis, cirrhosis, and end stage liver disease (ESLD) may eventually develop. PFIC was first described in Amish descendants of Jacob Byler, therefore it was originally called Byler disease. But it can be seen anywhere on the globe. This review summarizes the main features of the subtypes of the disease and discusses the current available diagnosis, conservative and surgical therapeutic options.
Keywords: biliary diversion; intrahepatic cholestasis; jaundice.
Conflict of interest statement
Disclosure The authors report no conflicts of interest in this work.
Figures
References
-
- Fawaz R, Baumann U, Ekong U, et al. Guideline for the evaluation of cholestatic jaundice in infants: Joint Recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroentero Nutr. 2017;64(1):154–168. - PubMed
-
- Ghent CN, Bloomer JR, Klatskin G. Elevations in skin tissue levels of bile acids in human cholestasis: relation to serum levels and to pruritus. Gastroenterology. 1977;73(5):1125–1130. - PubMed
-
- Wagner M, Zollner G, Trauner M. New molecular insights into the mechanisms of cholestasis. J Hepatol. 2009;51(3):565–580. - PubMed
-
- Jaquimene E. Progressive familial intrahepatic cholestasis. Clin Res Hepatol Gastroentrol. 2012;36(Suppl 1):S26–S35. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
